Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Channy Loeum"'
Publikováno v:
Croatian medical journal. 63(6)
To assess the difference between endotracheal tubes (ETT) with continuous suction of subglottic secretions (CASS) and standard ETT in preventing secretions movement from the pharynx into the trachea, past the inflated cuff during general anesthesia.T
Autor:
Jasmin R. Kastner, Gabriella Eisler, Marc C. Torjman, Abdurizzagh Khalf, David Diaz, Alek R. Dinesen, Channy Loeum, Paul J. Strasma, Jeffrey I Joseph
Publikováno v:
Journal of Diabetes Science and Technology. :193229682210933
Background: Infusion set function remains the limiting factor of insulin pump therapy due to nonmetabolic complications. Here, we tested an investigational extended-wear infusion set prototype with a soft, angled, wire-reinforced cannula with three a
Autor:
Ji-Bin Liu, Marc C. Torjman, Denise L Devine, Nance K Dicciani, Josiah Verkiak, Jeffrey I. Joseph, Channy Loeum
Publikováno v:
Hypertension. 76
The long-term Implantable Blood Pressure Waveform Monitoring System consists of a miniature applanation tonometer sensor head connected to a battery powered electronics module via a flexible lead. The BP Sensor continuously monitors the arterial BP w
Autor:
Abdurizzagh Khalf, Channy Loeum, Jeffrey I. Joseph, Paul J. Strasma, Marc C. Torjman, Gabriella J. Eisler
Publikováno v:
Diabetes. 68
There is great clinical need for an insulin infusion set that produces reliable and consistent insulin absorption (PK) from dose to dose and functions reliably for 7 or more days. Capillary Biomedical, Inc. is developing SteadiFlow technology which f
Autor:
Channy Loeum, Jasmin R Kastner, Marc C. Torjman, Paul J. Strasma, Abdurizzagh Khalf, Mathew L. Thakur, David Diaz, Alek R Dinesen, Gabriella J. Eisler, Jeffrey I. Joseph
Publikováno v:
BMJ Open Diabetes Research & Care
ObjectiveThis study investigated the effects of the inflammatory tissue response (ITR) to an insulin infusion set (IIS) on insulin bolus spread over wear time, as well as the effect of cannula insertion angle on the ITR, bolus shape, and pump tubing
Autor:
Jeffrey I. Joseph, Gabriella J. Eisler, David Diaz, Aleksandr R. Dinesen, Marc C. Torjman, Channy Loeum, Paul J. Strasma, Abdurizzagh Khalf
Publikováno v:
Diabetes. 67
Over 1 million people with diabetes use insulin pumps and insert a new continuous subcutaneous insulin infusion (CSII) set every 2-3 days for adequate blood glucose control. Insulin absorption from the subcutaneous tissue is slow and varies over time
Autor:
Channy Loeum, Jeffrey I. Joseph, David Diaz, Gabriella J. Eisler, Abdurizzagh Khalf, Marc C. Torjman
Subcutaneous (s.c.) glucose sensors have become a key component in type 1 diabetes management. However, their usability is limited by the impact of foreign body response (FBR) on their duration, reliability, and accuracy. Our study gives the first de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::686f16c4f42bf67e954a52e263741e64
https://europepmc.org/articles/PMC6110119/
https://europepmc.org/articles/PMC6110119/
Autor:
Jasmin R, Hauzenberger, Brian R, Hipszer, Channy, Loeum, Peter A, McCue, Mark, DeStefano, Marc C, Torjman, Mahmut T, Kaner, Alek R, Dinesen, Inna, Chervoneva, Thomas R, Pieber, Jeffrey I, Joseph
Publikováno v:
Diabetes Technology & Therapeutics
Background: Worldwide, ∼1 million people manage their type 1 diabetes with an insulin pump and a continuous subcutaneous insulin infusion (CSII) catheter. Patients routinely insert a new catheter every 2–3 days due to increasing variability of in
Autor:
Sarah Mycroft, Robert Machnicki, Channy Loeum, Jennifer Lessin, Marc C. Torjman, Jeffrey I. Joseph, Douglas Steinberger
Publikováno v:
Expert opinion on drug delivery. 14(1)
Introduction of a wearable device for subcutaneous delivery of larger volume bolus injections would encourage patient compliance and reduce the burden on healthcare services. With one such wearable device commercially available, this study examined t